期刊文献+

IL-17在低氧诱导肺动脉高压过程中的作用 被引量:5

Role of IL-17 in Hypoxia-induced Pulmonary Hypertension
下载PDF
导出
摘要 目的观察不同时程低氧诱导的肺动脉高压小鼠肺组织中IL-17mRNA及其蛋白表达水平的变化,探讨IL-17在低氧诱导肺动脉高压中的作用。方法建立小鼠低氧诱导肺动脉高压模型,监测小鼠血流动力学改变、右心室肥厚指数(RV/LV+S),RT-PCR技术检测对照组及低氧3周、6周组肺组织IL-17mRNA表达水平变化,Western blot技术检测相应蛋白表达水平变化及免疫组化方法对IL-17进行定位。结果与对照组相比,低氧诱导下小鼠右心室收缩压力及右心室肥厚指数均明显升高,且差异有统计学意义(均P<0.01),证实肺动脉高压模型成功建立。随着低氧时间的延长,IL-17mRNA及其蛋白表达水平也逐渐增加,差异均有统计学意义(P<0.05或P<0.01)。IL-17主要定位于内皮细胞,肺泡上皮细胞也有表达。结论 IL-17可能在低氧诱导肺动脉高压发生、发展过程中扮演了重要角色。 Objective To observe the changes of IL-7 mRNA and protein expressions in mouse pulmonary hypertension models induced by hypoxia for different time in an attempt to examine the role of IL-17 in hypoxia-induced pulmonary hypertension.Methods The mice were exposed to hypoxia for 3 or 6 weeks to establish hypoxia-induced pulmonary hypertension models.The hemodynamic changes of the mice were monitored.Right ventricular systolic pressure(RVSP)was measured by a right cardiac catheterization and right ventricular hypertrophy index[right ventricle to left ventricle plus interventricular septum(RV/LV+S)]was obtained.The pulmonary IL-17 mRNA expression was detected by RT-PCR and the IL-17 protein expression by Western blot.Immunohistochemical staining was used to examine the location of IL-17 in mouse pulmonary tissues.Results The RVSP and RV/(LV+S)were much higher in hypoxia-induced groups than in control group(P〈0.01),suggesting the success of the model establishment.The mRNA and protein expression levels of IL-17 were significantly increased with hypoxia time(P〈0.05 or P〈0.01).IL-17 mainly located in the endothelial cells,also in the alveolar epithelial cells.Conclusion IL-17 may play an important role in hypoxia-induced pulmonary hypertension.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期273-277,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 高等学校博士学科点专项科研基金资助项目(No.20110142110009)
关键词 肺动脉高压 白细胞介素-17 低氧诱导 内皮细胞 pulmonary hypertension interleukin-17 hypoxia-induced endothelial cells
  • 相关文献

参考文献3

二级参考文献99

  • 1Larche M,Robinson D S,Kay A B.The role of T lymphocytes in the pathogenesis of asthma[J].J Allergy Clin Immunol,2003,111(3):450-463.
  • 2Harrington L E,Hatton R D,Mangan P R,et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol,2005,6(11):1123-1132.
  • 3Bettelli E,Korn T,Oukka M,et al.Induction and effector functions of T(H)17 cells[J].Nature,2008,453(7198):1051-1057.
  • 4Harrington L E,Mangan P R,Weaver C T.Expanding the effector CD4 T-cell repertoire:the Th17 lineage[J].Curr Opin Immunol,2006,18(3):349-356.
  • 5Langrish C L,Chen Y,Blumenschein W M,et al.IL-23 drives a pathogenic T cell population that induces autoimmune inflammation[J].J Exp Med,2005,201(2):233-240.
  • 6Park H,Li Z,Yang X O,et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J].Nat Immunol,2005,6(11):1133-1141.
  • 7Molet S,Hamid Q,Davoine F,et al.IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines[J].J Allergy Clin Immunol,2001,108(3):430-438.
  • 8Pene J,Chevalier S,Preisser L,et al.Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes[J].J Immunol,2008,180(11):7423-7430.
  • 9Bullens D M,Truyen E,Coteur L,et al.IL-17 mRNA in sputum of asthmatic patients:linking T cell driven inflammation and granulocytic influx[J].Respir Res,2006,7(1):135.
  • 10Ordonez C L,Shaughnessy T E,Matthay M A,et al.Incr-eased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma.Clinical and biological significance[J].Am J Respir Crit Care Med,2000,161(1):1185-1190.

共引文献30

同被引文献54

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2013
  • 2李萍,何秀娟,张颖,王芳,盛巡,刘欣,梁代英,邱全瑛.黄芪多糖对细胞增殖及血管内皮细胞与白细胞粘附作用的影响[J].中国病理生理杂志,2004,20(9):1677-1680. 被引量:28
  • 3宋淑珍,田亚平,汪德清,王玲,姜辉,董矜,张阳东.黄芪多糖对健康体检者淋巴细胞亚群的调节作用[J].中国临床康复,2005,9(11):130-131. 被引量:34
  • 4蔡莉,朱江.黄芪多糖研究现状与进展[J].中国肿瘤临床,2007,34(15):896-900. 被引量:82
  • 5Araneda OF,Tuesta M. Lung Oxidative Damage by Hypoxia [ J ]. Oxidative Medicine and Cellular Longevity ,2012:1 -18.
  • 6Humbert M, Montani D, Oleg V,et al. Definition and Classifica- tion of Pulmonary Hypertension [ M ]. Handbook of experimental pharmacology ,2013,218:3 - 29.
  • 7Jyothula S, Safdar Z, Update on pulmonary hypertension complica- ting chronic obstructive pulmonary disease [ J ]. Int J Chron Ob- struct Pulmon Dis, 2009, 4 : 351 - 63.
  • 8Erik R, Swenson ER. Hypoxic Pulmonary Vasoconstriction [J ]. High Altitude Medicine & Biology, 2013, 14(2) : 101 -110.
  • 9Wang Z, Li AY, Guo QH,et al. Effects of Cyclic Intermittent Hy- poxia on ET-1 Responsiveness and Endothelial Dysfunction of Pul- monary Arteries in Rats[J]. PLoS ONE, 2013, 8(3) : e58078.
  • 10Shao D, Park JES, Wort SJ. The role of endothelin-1 in the patho- genesis of pulmonary arterial hypertension [ J ]. Pharmacological Research, 2011, 63(6) : 504 -511.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部